A double blind clinical trial in weight control; Use of fenfluramine and phentermine alone and in combination
Weintraub M., Hasday J.D., Mushlin A.I., Lockwood D.H. A double blind clinical trial in weight control; use of fenfluramine and phentermine alone and in combination. Arch Intern Med. 144:1984;1143-1148.
A population-based study of appetite suppressant drugs and the risk of cardiac-valve regurgitation
Jick H., Vasilakis C., Weinrauch L.A., Meier C.R., Jick S.S., Derby L.E. A population-based study of appetite suppressant drugs and the risk of cardiac-valve regurgitation. N Engl J Med. 339:1998;719-724.
The prevalence of cardiac valvular insufficiency assessed by trans thoracic echocardiography in obese patients treated with appetite-suppressant drugs
Khan M.A., Herzog C.A., St Peter J.V., et al. The prevalence of cardiac valvular insufficiency assessed by trans thoracic echocardiography in obese patients treated with appetite-suppressant drugs. N Engl J Med. 339:1998;713-718.
Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echo-cardiography
Robiolio P.A., Rigolin V.H., Wilson J.S., et al. Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echo-cardiography. Circulation. 92:1995;790-795.
Regression of multivalvular regurgitation after cessation of fenfluramine and phentermine treatment
[Letter]
Cannistra L.B., Cannistra A.J. Regression of multivalvular regurgitation after cessation of fenfluramine and phentermine treatment. [Letter] N Engl J Med. 339:1998;771.